中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
腺苷 | adenosine | 58-61-7 | C10H13N5O4 | 267.244 |
2-氯腺嘌呤核苷 | 2-Chloroadenosine | 146-77-0 | C10H12ClN5O4 | 301.689 |
8-溴膘苷 | 8-bromoadenosine | 2946-39-6 | C10H12BrN5O4 | 346.14 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | O2;,O3',O5'-tris-trimethylsilyl-N6-benzoyladenosine | 118684-36-9 | C26H41N5O5Si3 | 587.899 |
腺苷 | adenosine | 58-61-7 | C10H13N5O4 | 267.244 |
—— | O2;,O3',O5'-tris-trimethylsilyl-N6,N6-dibenzoyladenosine | 610305-23-2 | C33H45N5O6Si3 | 692.007 |
—— | N6-acetyl-adenosine | 16265-37-5 | C12H15N5O5 | 309.282 |
—— | 6-N-butanoyl-adenosine | 4662-11-7 | C14H19N5O5 | 337.335 |
—— | N6-[(2-cyanoethoxy)carbonyl]adenosine | 328238-49-9 | C14H16N6O6 | 364.318 |
N6-苯甲酰基-3',5'-O-(1,1,3,3-四异丙基-1,3-二硅氧烷二基腺苷 | 3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-N6-benzoyladenosine | 79154-57-7 | C29H43N5O6Si2 | 613.861 |
N6-苯甲酰基腺苷 | N-benzoyladenosine | 4546-55-8 | C17H17N5O5 | 371.352 |
N-(苯氧基乙酰基)腺苷 | N6-phenoxyacetyladenosine | 119824-65-6 | C18H19N5O6 | 401.379 |
—— | 5′-O-(dimethoxytrityl)-2′-O-(tert-butyldimethylsilyl)-N6-phenoxyacetyladenosine | 121058-83-1 | C45H51N5O8Si | 818.014 |
—— | N6-2,2,2-trichloro-tert-butoxycarbonyl-adenosine | 80035-45-6 | C15H18Cl3N5O6 | 470.697 |
—— | (2R,3S,4R,5R)-2-(6-amino-9H-purin-9-yl)-4-fluoro-5-(hydroxymethyl)tetrahydrofuran-3-ol | 20535-16-4 | C10H12FN5O3 | 269.235 |
—— | 2',5'-di-O-(p-toluenesulfonyl)adenosine | 127246-62-2 | C24H25N5O8S2 | 575.623 |
N6-单丁酰基腺苷-3',5'-环单磷酸 | N6-monobutyryl cAMP | 13117-60-7 | C14H18N5O7P | 399.3 |
—— | 6-N-benzoyl-9-(5-O-tert-butyldiphenylsilyl-β-D-ribofuranosyl)adenine | 77244-83-8 | C33H35N5O5Si | 609.757 |
N-苯甲酰基-3'-脱氧腺苷 | 3'-deoxy-N6-benzoyladenosine | 76902-49-3 | C17H17N5O4 | 355.353 |
—— | N6,N6-dibenzoyladenosine | 51008-81-2 | C24H21N5O6 | 475.461 |
—— | 9H-fluoren-9-ylmethyl N-[9-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetra(propan-2-yl)-6a,8,9,9a-tetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]purin-6-yl]carbamate | 110744-77-9 | C37H49N5O7Si2 | 731.996 |
—— | N6-acetyl-5'-O-(4,4'-dimethoxytrityl)adenosine | 231957-26-9 | C33H33N5O7 | 611.654 |
5'-O-[二(4-甲氧基苯基)苯基甲基]-N-(苯氧基乙酰基)腺苷 | 5'-O-dimethoxytrityl-N6-phenoxyacetyladenosine | 121076-16-2 | C39H37N5O8 | 703.751 |
—— | N(6)-(9-fluorenylmethoxycarbonyl)-adenosine | 87424-17-7 | C25H23N5O6 | 489.488 |
—— | Diisopropyl-phosphoramidous acid (2R,3R,4R,5R)-2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-(tert-butyl-dimethyl-silanyloxy)-5-[6-(2-phenoxy-acetylamino)-purin-9-yl]-tetrahydro-furan-3-yl ester 2-cyano-ethyl ester | 121058-86-4 | C54H68N7O9PSi | 1018.23 |
—— | 6-N-<2-<(tert-butyldiphenylsilyl)methyl>benzoyl>-adenosine | 143294-14-8 | C34H37N5O6Si | 639.783 |
—— | 9-[3-deoxy-3-fluoro-2,5-di-O-(p-toluenesulfonyl)-β-D-xylopyranosyl]adenine | 190773-84-3 | C24H24FN5O7S2 | 577.614 |
—— | {9-[(2R,3R,4R,5R)-4-Hydroxy-5-hydroxymethyl-3-(4-methoxy-tetrahydro-pyran-4-yloxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-carbamic acid 9H-fluoren-9-ylmethyl ester | 110744-79-1 | C31H33N5O8 | 603.632 |
—— | {9-[(2R,3R,4R,5R)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(4-methoxy-tetrahydro-pyran-4-yloxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-carbamic acid 9H-fluoren-9-ylmethyl ester | 110744-81-5 | C52H51N5O10 | 906.004 |
Adenine nucleotide (AN) 2nd messengers, such as 3′,5′-cyclic adenosine monophosphate (cAMP), are central elements of intracellular signaling, but many details of their underlying processes remain elusive. Like all nucleotides, cyclic nucleotide monophosphates (cNMPs) are net-negatively charged at physiologic pH which limits their applicability in cell-based settings. Thus, many cellular assays rely on sophisticated techniques like microinjection or electroporation. This setup is not feasible for medium- to high-throughput formats, and the mechanic stress that cells are exposed to raises the probability of interfering artefacts or false-positives. Here, we present a short and flexible chemical route yielding membrane-permeable, bio-reversibly masked cNMPs for which we employed the octanoyloxybenzyl (OB) group. We further show hydrolysis studies on chemical stability and enzymatic activation, and present results of real-time assays, where we used cAMP and Ca2+ live cell imaging to demonstrate high permeability and prompt intracellular conversion of some selected masked cNMPs. Based on these results, our novel OB-masked cNMPs constitute valuable precursor-tools for non-invasive studies on intracellular signaling.